Insider Transactions in Q4 2022 at Agilon Health, Inc. (AGL)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$86,368
$16.82 P/Share
|
|
Dec 16
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Dec 15
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$91,766
$17.42 P/Share
|
|
Dec 15
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Dec 15
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-42.25%
|
$318,750
$17.26 P/Share
|
|
Dec 15
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+29.7%
|
$56,250
$3.0 P/Share
|
|
Dec 14
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-42.25%
|
$318,750
$17.52 P/Share
|
|
Dec 14
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+29.7%
|
$56,250
$3.0 P/Share
|
|
Dec 06
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$91,766
$17.72 P/Share
|
|
Dec 06
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Dec 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,398
-34.11%
|
$91,766
$17.8 P/Share
|
|
Dec 05
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,398
+25.44%
|
$21,592
$4.49 P/Share
|
|
Nov 18
2022
|
Steven Sell CEO & President |
BUY
Open market or private purchase
|
Indirect |
2,900
+50.0%
|
$49,300
$17.14 P/Share
|
|
Nov 17
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$91,732
$17.43 P/Share
|
|
Nov 17
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Nov 17
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-42.25%
|
$318,750
$17.17 P/Share
|
|
Nov 17
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+29.7%
|
$56,250
$3.0 P/Share
|
|
Nov 16
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$97,128
$18.52 P/Share
|
|
Nov 16
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Nov 16
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-42.25%
|
$337,500
$18.29 P/Share
|
|
Nov 16
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+29.7%
|
$56,250
$3.0 P/Share
|
|
Nov 02
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$102,524
$19.53 P/Share
|
|
Nov 02
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Nov 01
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$107,920
$20.03 P/Share
|
|
Nov 01
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Oct 20
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
29,548
-28.18%
|
$590,960
$20.51 P/Share
|
|
Oct 20
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,548
+34.88%
|
$88,644
$3.0 P/Share
|
|
Oct 19
2022
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
20,452
-22.91%
|
$409,040
$20.23 P/Share
|
|
Oct 19
2022
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,452
+30.74%
|
$61,356
$3.0 P/Share
|
|
Oct 17
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$113,316
$21.79 P/Share
|
|
Oct 17
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Oct 14
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
5,396
-34.1%
|
$113,316
$21.79 P/Share
|
|
Oct 14
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,396
+25.43%
|
$21,584
$4.49 P/Share
|
|
Oct 04
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$194,256
$24.27 P/Share
|
|
Oct 04
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$32,376
$4.49 P/Share
|
|
Oct 03
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-43.7%
|
$186,162
$23.17 P/Share
|
|
Oct 03
2022
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+30.41%
|
$32,376
$4.49 P/Share
|
|
Oct 03
2022
|
Priscilla Kasenchak Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,352
+50.0%
|
-
|